Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Biotree Biological Technology is a leading Chinese high-tech enterprise specializing in metabolomics and multi-omics research services. Founded in 2012 and headquartered in Shanghai, the company provides comprehensive solutions including untargeted and targeted metabolomics, lipidomics, proteomics, and transcriptomics to support clinical research, drug discovery, and agricultural science. Biotree operates advanced mass spectrometry platforms and has developed proprietary bioinformatics tools and a vast metabolite library to assist researchers in identifying biomarkers and understanding biological mechanisms. The company serves over 2,500 entities globally, including academic institutions, hospitals, and pharmaceutical companies, and has expanded into the development of IVD kits and pre-clinical CRO services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai BIOTREE Biological Technology.